Huiliang Qiu, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Guangzhou University of Chinese Medicine, Guangzhou, ChinaPh.D06/2019Basic Research in Cardiology
    Guangzhou University of Chinese Medicine, Guangzhou, ChinaMD06/2014Medicine
    Collapse Awards and Honors
    American Heart Association2020  - 2021AHA Postdoctoral Fellowship

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Deciphering mechanism of the herbal formula WuShen in the treatment of postinfarction heart failure. Phytomedicine. 2022 Jan; 95:153878. Qiu H, Huang ZY, Cao H, Zhang Z, Ma J, Li XQ, Huang S, Li X, Qiu W, Zhao Z, Ji C, Huang L, Jiang W, Yang ZQ, Xian SX, Wu H, Lu W, Ding C. PMID: 34929563.
      View in: PubMed   Mentions:
    2. Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction. Adv Funct Mater. 2020 Oct 22; 30(43). Fang J, Koh J, Fang Q, Qiu H, Archang MM, Hasani-Sadrabadi MM, Miwa H, Zhong X, Sievers R, Gao DW, Lee R, Carlo DD, Li S. PMID: 33708028; PMCID: PMC7942842.
      View in: PubMed   Mentions: 3  
    3. Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling pathway. Naunyn Schmiedebergs Arch Pharmacol. 2020 08; 393(8):1527-1539. Liu H, Liu W, Qiu H, Zou D, Cai H, Chen Q, Zheng C, Xu D. PMID: 31853618; PMCID: PMC7351826.
      View in: PubMed   Mentions:
    4. Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins. Front Physiol. 2018; 9:1726. Qiu H, Ji C, Liu W, Wu Y, Lu Z, Lin Q, Xue Z, Liu X, Wu H, Jiang W, Zou C. PMID: 30564139; PMCID: PMC6288485.
      View in: PubMed   Mentions: 8  
    5. Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure. Drug Des Devel Ther. 2018; 12:3407-3418. Ma J, Yin C, Ma S, Qiu H, Zheng C, Chen Q, Ding C, Lv W. PMID: 30349194; PMCID: PMC6186904.
      View in: PubMed   Mentions:
    6. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats. Phytomedicine. 2018 Dec 01; 51:255-265. Qiu H, Liu W, Lan T, Pan W, Chen X, Wu H, Xu D. PMID: 30466624.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    7. Chronic kidney disease-induced atrial structural remodeling and atrial fibrillation: more studies on the pathological mechanism are encouraged. Naunyn Schmiedebergs Arch Pharmacol. 2018 07; 391(7):671-673. Qiu H, Ji C, Wu H, Zou C. PMID: 29744559.
      View in: PubMed   Mentions:
    8. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats. Eur J Pharmacol. 2018 Jun 15; 829:102-111. Lan TH, Chen XL, Wu YS, Qiu HL, Li JZ, Ruan XM, Xu DP, Lin DQ. PMID: 29665366.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    9. DL-3-n-butylphthalide improves ventricular function, and prevents ventricular remodeling and arrhythmias in post-MI rats. Naunyn Schmiedebergs Arch Pharmacol. 2018 06; 391(6):627-637. Qiu H, Ma J, Wu H, Ding C. PMID: 29602954.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    10. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure. Naunyn Schmiedebergs Arch Pharmacol. 2018 03; 391(3):323-334. Qiu H, Wu H, Ma J, Cao H, Huang L, Qiu W, Peng Y, Ding C. PMID: 29290021.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    11. Traditional Chinese Medicine ShenZhuGuanXin Granules Mitigate Cardiac Dysfunction and Promote Myocardium Angiogenesis in Myocardial Infarction Rats by Upregulating PECAM-1/CD31 and VEGF Expression. Evid Based Complement Alternat Med. 2017; 2017:5261729. Xu DP, Zou DZ, Qiu HL, Wu HL. PMID: 28757887; PMCID: PMC5512036.
      View in: PubMed   Mentions: 4  
    Huiliang's Networks
    Concepts (64)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California